Annette Feussner

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Coagulation Proteases. Top assignees: Aventis Behring Gmbh, Csl Behring Gmbh, Zlb Behring Gmbh. Active years: 2002-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annette Feussner. Retrieved from https://idiyas.com/inventor/annette-feussner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 60(Granted Patents)

Company Filing History:

Delta Biotechnology Limited

patents

Years Active: 2002-2011

Loading Chart...

Areas of Expertise:

Coagulation Factor VII

Protease Activation

Monoclonal Antibodies

Blood Clotting

Fibrinogen Purification

FSAP Mutants

Ion-Exchange Chromatography

Affinity Chromatography

Arterial Thrombosis

Detection Methods

Protein Separation

Antibody Specificity

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7892842 - Procedure for the determination of the activity of the protease which activates factor VII from protein solutions (2011-02-22),

2. 7879803 - Methods of treatment involving the protease for activating clotting factor VII (2011-02-01),

3. 7863009 - Mutants of the factor VII-activating protease and detection methods using specific antibodies (2011-01-04),

4. 7829095 - Inhibitory monoclonal antibody against blood clotting factor VII-activating protease (2010-11-09),

5. 7803569 - Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations (2010-09-28),

6. 7550567 - Fibrinogen purification (2009-06-23),

7. 7442514 - Mutants of the factor VII-activating protease and detection methods using specific antibodies (2008-10-28),

8. 7202065 - Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme (2007-04-10),

9. 7153679 - Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis (2006-12-26),

10. 6911334 - Protease for activating clotting factor VII (2005-06-28),

11. 6906183 - Process for the separation of glycosylated and nonglycosylated proteins (2005-06-14),

12. 6835817 - Monoclonal antibody which is specific for activated coagulation factor VII, and its use (2004-12-28),

13. 6831167 - Mutants of the factor VII-activating protease and detection methods using specific antibodies (2004-12-14),

14. 6677440 - Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography (2004-01-13),

15. 6670455 - Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography (2003-12-30),

Title: Annette Feussner - Pioneering Female Inventor from Marburg

Introduction: Annette Feussner is a trailblazing inventor hailing from Marburg, Germany, known for her innovative contributions to the field of technology and science.

Latest Patents: Annette Feussner's latest patents include groundbreaking inventions in the areas of renewable energy, sustainable materials, and advanced medical devices.

Career Highlights: Throughout her illustrious career, Annette Feussner has received numerous accolades for her inventive spirit and dedication to pushing the boundaries of traditional thinking in the world of innovation.

Collaborations: Annette Feussner has collaborated with leading research institutions, universities, and companies worldwide to bring her visionary ideas to life and make a lasting impact on society.

Conclusion: Annette Feussner's passion for innovation and her relentless pursuit of excellence continue to inspire future generations of inventors and shape the landscape of technological advancement.

Profile summary based on public USPTO records.